ArticleRevista medica del Instituto Mexicano del Seguro Social2024
[Hypereosinophilic syndrome, case report and diagnostic approach].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypereosinophilic syndrome (HES) is a rare hematological disorder, characterized by blood and tissue eosinophilia, causing tissue damage and dysfunction. The onset of the disease is generally asymptomatic, being discovered incidentally. The objective of this article is to illustrate the rare clinical presentation in patients with chronic kidney disease. Clinical case: A 69-year-old male patient, with a history of type 2 diabetes and high blood pressure, was admitted to the internal medicine service with wasting syndrome under study, multiple urticarial skin lesions and peripheral blood cytopenias. During the approach to him, eosinophilia of more than 5.0 × 109 / L was evidenced, a bone marrow aspirate was performed, which revealed eosinophilic infiltration with dysplasia, biopsy of dermal lesions with mixed cellular infiltrate with a predominance of eosinophils; With the above, the diagnosis of idiopathic HES is made, after the exclusion of other evident eosinophilia etiologies. Systemic steroid treatment was started. Conclusions: Eosinophilic disorders represent a heterogeneous group of rare conditions, with multiple clinical manifestations, predominantly dermatological. An important association with the development of chronic kidney disease is reported, so a comprehensive approach must be carried out, with the aim of achieving an etiological diagnosis that allows early treatment and improves survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.